Funding · Company
Glympse Bio, Inc.
Cambridge, MABiotech & Pharma
Glympse Bio, Inc. of Cambridge, MA has disclosed $70M across 2 Form D offerings filed with the SEC between Jul 1, 2021 and May 12, 2023.
$70M
Total disclosed
2
Form D offerings
This CIK has filed under more than one name: SunBird Bio, Inc., Glympse Bio, Inc.. We use the most recent.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001749272Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →